Iveta Štempeľová, Pharm.D.

Last update: 09. 05. 2023

I. BASIC INFORMATION
I.1 Surname Štempeľová
I.2 Name Iveta
I.3 Titles Pharm.D.
I.4 Year of birth 1989
I.5 Name of the workplace University of Veterinary Medicine and Pharmacy in Košice, Department of Pharmacy and Social Pharmacy
I.6 Address of the workplace Komenského 73, 041 81 Košice, Slovak Republic
I.7 Position assistant lecturer
I.8 E-mail address iveta.stempelova@uvlf.sk
I.9 Hyperlink to the entry of a person in the Register of university staff https://www.portalvs.sk/regzam/detail/30305
I.10 Name of the study field in which a person works at the university pharmacy
I.11 ORCID iD 3
3 Optional item.

II. HIGHER EDUCATION AND FURTHER QUALIFICATION GROWTH
II.a Name of the university or institution II.b Year II.c Study field and programme
II.1 First degree of higher education
II.2 Second degree of higher education University of Veterinary Medicine and Pharmacy in Košice 2013 pharmacy
II.3 Third degree of higher education
II.4 Associate professor
II.5 Professor
II.6 Doctor of Science (DrSc.)

III. CURRENT AND PREVIOUS EMPLOYMENT
III.a Occupation-position III.b Institution III.c Duration
DEPARTMENT OF PHARMACY AND SOCIAL PHARMACY - assistant University of Veterinary Medicine and Pharmacy in Košice 2018 up to now
Ivana pharmacy - pharmacist Ivana pharmacy, Maršála Koneva 1, 040 01 Košice 2017 2018
Dr. Max pharmacy - pharmacist Dr. Max pharmacy, Libušina třída 578/19, 623 00 Brno 2014 2016
Dr. Max pharmacy - pharmacist Dr. Max pharmacy, Obchodní ulice 30, Jenišov-362, Carlsbad 2013 2014

IV. DEVELOPMENT OF PEDAGOGICAL, PROFESSIONAL, LANGUAGE, DIGITAL AND OTHER SKILLS
IV.a Activity description, course name, other IV.b Name of the institution IV.c Year
INTED2023 17th annual International Technology, Education and Development Conference The International Academy of Technology, Education and Development (IATED) 2023
The 19th eLearning and Software for Education Conference - eLSE 2023 National Defence University and European Security and Defence College (ESDC) 2023
The Spotlight Telemedicine Conference The Spotlight Telemedicine Conference, STEPHANE TALBOOM (Organizer), MARTIN NAGILLER (Organizer) 2021
EUROPEAN HEALTH CONFERENCE HIMSS21EUROPE 2021

V. OVERVIEW OF ACTIVITIES WITHIN THE TEACHING CAREER AT THE UNIVERSITY
V.1. Overview of the profile courses taught in the current academic year according to study programmes
V.1.a Name of the profile course V.1.b Study programme V.1.c Degree V.1.d Field of study

V.2. Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year 4
V.2.a Study programme V.2.b Degree V.2.d Field of study
4 According to Art. 6 para. 4 of the Standards for the Study Programme.

V.3. Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.3.a Name of the field of habilitation procedure and inaugural procedure V.3.b Study field to which it is assigned

V.4. Overview of supervised final theses
V.4.a Bachelor's (first degree) V.4.b Diploma (second degree) V.4.c Dissertation (third degree)
V.4.1 Number of currently supervised theses 0 1 0
V.4.2 Number of defended theses 0 4 0

V.5. Overview of other courses taught in the current academic year according to study programmes
V.5.a Name of the course V.5.b Study programme V.5.c Degree V.5.d Field of study

VI. OVERVIEW OF THE RESEARCH/ARTISTIC/OTHER OUTPUTS
VI.1. Overview of the research/artistic/other outputs and the corresponding citations
VI.1.a Overall VI.1.b Over the last six years
VI.1.1 Number of the research/artictic/other outputs 21 16
VI.1.2 Number of the research/artictic/other outputs registered in the Web of Science or Scopus databases 0 0
VI.1.3 Number of citations corresponding to the research/artictic/other outputs 0 0
VI.1.4 Number of citations registered in the Web of Science or Scopus databases 0 0
VI.1.5 Number of invited lectures at the international, national level

VI.2. The most significant research/artistic/other outputs 5
1. ŠTEMPEĽOVÁ, Iveta - FEDOROVÁ, Monika. Oftalmologiká a ich pomocné látky so známym účinkom (prehľadový článok) : [Ophthalmologicals and their excipients with a known effect (a review)] In: Folia Pharmaceutica Cassoviensia. 2021. ISSN 2585-9609, Roč. 3, č. 3 (2021), s. 29-37.
2. ŠTEMPEĽOVÁ, Iveta - FEDOROVÁ, Monika. Botulotoxín v terapii sialorey pri Parkinsonovej chorobe. In: Zjazd Slovenskej farmaceutickej spoločnosti : Quo vadis scientia pharmaceutica. Farmaceutický obzor. 2019. ISSN 0014-8172, Roč. 88, č. 7-8 (2019), s.175.
3. ŠTEMPEĽOVÁ, Iveta - FEDOROVÁ, Monika. Zdravotné riziká pomocných látok voľnopredajných liekov používaných v liečbe zápalov ústnej dutiny a hltana z pohľadu farmaceuta : [Health risks of excipients used in production of over the counter medicines used in oral cavity and pharynx treatment of inflammation in the view of pharmacist] In: Škola-Veda-Prax : konferencia. Škola - Veda - Prax, 17.-18. september 2019, Košice : Zborník referátov a abstraktov: vedecká konferencia pri príležitosti 70. výročia založenia UVLF v Košiciach. 1. vyd. Košice : UVLF, 2019. ISBN 978-80-8077-628-2, CD-ROM, s. 222.
4. ŠTEMPEĽOVÁ, Iveta - FEDOROVÁ, Monika. Možnosti terapie neskorých motorických komplikácií indukovaných levodopou. In: Zjazd Slovenskej farmaceutickej spoločnosti : Quo vadis scientia pharmaceutica. Farmaceutický obzor. 2019. ISSN 0014-8172, Roč. 88, č. 7-8 (2019), s.175.
5 Maximum of five most significant outputs, if the RATP form is attached to the application.

VI.3. The most significant research/artistic/other outputs over the last six years 6
1. ŠTEMPEĽOVÁ, Iveta - FEDOROVÁ, Monika. Oftalmologiká a ich pomocné látky so známym účinkom (prehľadový článok) : [Ophthalmologicals and their excipients with a known effect (a review)] In: Folia Pharmaceutica Cassoviensia. 2021. ISSN 2585-9609, Roč. 3, č. 3 (2021), s. 29-37.
2. ŠTEMPEĽOVÁ, Iveta - FEDOROVÁ, Monika. Botulotoxín v terapii sialorey pri Parkinsonovej chorobe. In: Zjazd Slovenskej farmaceutickej spoločnosti : Quo vadis scientia pharmaceutica. Farmaceutický obzor. 2019. ISSN 0014-8172, Roč. 88, č. 7-8 (2019), s.175.
3. ŠTEMPEĽOVÁ, Iveta - FEDOROVÁ, Monika. Možnosti terapie neskorých motorických komplikácií indukovaných levodopou. In: Zjazd Slovenskej farmaceutickej spoločnosti : Quo vadis scientia pharmaceutica. Farmaceutický obzor. 2019. ISSN 0014-8172, Roč. 88, č. 7-8 (2019), s.175.
6 Maximum of five most significant outputs over the last six years, if the RATP form is attached to the application.

VI.4. The most significant citations corresponding to the research/artistic/other outputs 7
7 Maximum of five most significant citations, if the RATP form is attached to the application.

VI.5. Participation in conducting (leading) the most important research projects or art projects over the last six years 8
8 Maximum of five most significant projects, if the RATP form is attached to the application. In addition to the name and brief characteristics of the project, the type of participation is indicated (in Slovak and in English), if possible, a hyperlink to the project and its outputs and citations are stated as well.

VII. OVERVIEW OF ORGANIZATIONAL EXPERIENCE RELATED TO HIGHER EDUCATION AND RESEARCH/ARTISTIC/OTHER ACTIVITIES 9
VII.a Activity, position VII.b Name of the institution, board VII.c Duration
member Slovak Chamber of Pharmacists 2018 up to now
9 E.g. academic positions, memberships in editorial boards and in scientific and professional societies.

VIII. OVERVIEW OF INTERNATIONAL MOBILITIES AND VISITS ORIENTED ON EDUCATION AND RESEARCH/ARTISTIC/ OTHER ACTIVITIES IN THE GIVEN FIELD OF STUDY
VIII.a Name of the institution VIII.b Address of the institution VIII.c Duration (indicate the duration of stay) VIII.d Mobility scheme, employment contract, other (describe)

IX. OTHER RELEVANT FACTS 10
IX.a If relevant, other activities related to higher education or research/artictic/other activities are mentioned
Doctoral studies from 2019 (Masaryk University, Faculty of Pharmacy, Brno)
10 Maximum of 1800 characters, if the RATP form is attached to the application.
Skip to content